Filter

231 - 240 of 337 Results

  • New Online Resource Tracks Legislation Affecting Global Health 

    News Release

    A new KFF online resource tracks more than 30 bills introduced in the current Congress that would affect global health policy. The U.S. Global Health Legislation Tracker covers current legislation on an array of topics, from implementing a strategy to help end preventable maternal and child deaths to creating an action plan on climate change. There is also legislation regarding reproductive health, global health security, and LGBTI issues. The tracker captures each bill’s title, sponsors…

  • Initiative 18|11: What Can We Do About The Cost Of Health Care?

    Issue Brief

    This conference report summarizes discussions at a March 2018 conference in Washington with 30 leaders from the health care community to launch Initiative 18/11, a partnership between the Society of Actuaries and KFF to address the rising cost of health care in the United States. It also lays out the next steps for the initiative.

  • 2013 Survey of Americans on the U.S. Role in Global Health

    Poll Finding

    The 2013 Survey of Americans on the U.S. Role in Global Health examines the American public's views, knowledge and opinions of U.S. efforts to improve health for people in developing countries. The fifth in a series that began in 2009, the survey explores the public's views on global health spending and foreign aid, their priorities for the U.S. in world affairs, and the attention they pay to the issue of health in developing countries.

  • What’s the Latest on Medicare Drug Price Negotiations?

    Issue Brief

    In response to prescription drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing the federal government to negotiate the price of prescription drugs for Medicare and private payers. This brief describes the current status of drug price negotiation proposals, looks back at the history of proposals to give the federal government the authority to negotiate drug prices in Medicare, describes the negotiation provisions in key legislation (H.R. 3), and discusses…

  • Unpacking the Prescription Drug Provisions of the Build Back Better Act

    Event Date:
    Event

    As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs. The House-passed bill would allow the federal government to negotiate prices for some high-cost drugs in Medicare, and set a hard cap on out-of-pocket drug spending for Medicare Part D enrollees.  For people with Medicare and private insurance, the legislation would limit annual increases in drug prices and cap…